Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-027625

Options or other derivatives

  • Director acquired 2,513 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ferrante Karen Jean · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-07-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,513 $4.78 $12,001 2,513 D
Loading xslF345X03/doc4.xml…